Behind the Mystery: Why We Started the Series
February 29, 2020
Behind the Mystery co-creators Molly Mager and Carri Levy talk about what prompted them to start the series. Molly’s twin brother was diagnosed with acinar cell cystadenoma at the age of 25, while Carri’s daughter Ilana Jacqueline suffered for years before being diagnosed with Primary Immune Deficiency Disease.
We are excited to celebrate #RareDiseaseDay this February 29th, 2020. For this, we’ll be sharing our favorite patient stories to help raise awareness and give a voice to those who need one. Join us on this day!
A specialized, recurring segment on The Balancing Act, Behind the Mystery is devoted to rare and genetic diseases. It highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. Its goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies, while giving voices to the patients, families, and advocates affected via our national television platform airing on Lifetime. https://thebalancingact.com/category/… www.linkedin.com/company/behind-the-mystery
Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.
Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.
Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.